CY1106385T1 - Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου - Google Patents
Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμουInfo
- Publication number
- CY1106385T1 CY1106385T1 CY20071100363T CY071100363T CY1106385T1 CY 1106385 T1 CY1106385 T1 CY 1106385T1 CY 20071100363 T CY20071100363 T CY 20071100363T CY 071100363 T CY071100363 T CY 071100363T CY 1106385 T1 CY1106385 T1 CY 1106385T1
- Authority
- CY
- Cyprus
- Prior art keywords
- subparathyroidism
- treatment
- epothilone derivatives
- epothilone
- animal
- Prior art date
Links
- 150000003883 epothilone derivatives Chemical class 0.000 title abstract 2
- 201000002980 Hyperparathyroidism Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41859202P | 2002-10-15 | 2002-10-15 | |
| PCT/IB2003/004514 WO2004035050A1 (en) | 2002-10-15 | 2003-10-13 | Use of epothilone derivatives for the treatment of hyperparathyroidism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106385T1 true CY1106385T1 (el) | 2011-10-12 |
Family
ID=32107949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100363T CY1106385T1 (el) | 2002-10-15 | 2007-03-15 | Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060142354A1 (https=) |
| EP (1) | EP1553938B1 (https=) |
| JP (1) | JP4672368B2 (https=) |
| CN (1) | CN1297269C (https=) |
| AT (1) | ATE350034T1 (https=) |
| AU (1) | AU2003267751A1 (https=) |
| BR (1) | BR0315293A (https=) |
| CA (1) | CA2501717C (https=) |
| CY (1) | CY1106385T1 (https=) |
| DE (1) | DE60310975T2 (https=) |
| DK (1) | DK1553938T3 (https=) |
| ES (1) | ES2279139T3 (https=) |
| PT (1) | PT1553938E (https=) |
| SI (1) | SI1553938T1 (https=) |
| WO (1) | WO2004035050A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60330407D1 (de) | 2002-08-23 | 2010-01-14 | Sloan Kettering Inst Cancer | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1155689B1 (en) * | 1993-07-19 | 2006-09-20 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic stents and methods of their preparation |
| DK1367057T3 (da) * | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
| US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| SK287775B6 (sk) * | 1998-02-05 | 2011-09-05 | Novartis Ag | Farmaceutická formulácia obsahujúca epothilon, infúzny roztok a použitie farmaceutickej formulácie |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
-
2003
- 2003-10-13 CA CA2501717A patent/CA2501717C/en not_active Expired - Fee Related
- 2003-10-13 BR BR0315293-6A patent/BR0315293A/pt not_active IP Right Cessation
- 2003-10-13 SI SI200330741T patent/SI1553938T1/sl unknown
- 2003-10-13 PT PT03748446T patent/PT1553938E/pt unknown
- 2003-10-13 US US10/530,855 patent/US20060142354A1/en not_active Abandoned
- 2003-10-13 ES ES03748446T patent/ES2279139T3/es not_active Expired - Lifetime
- 2003-10-13 EP EP03748446A patent/EP1553938B1/en not_active Expired - Lifetime
- 2003-10-13 CN CNB200380101281XA patent/CN1297269C/zh not_active Expired - Fee Related
- 2003-10-13 AU AU2003267751A patent/AU2003267751A1/en not_active Abandoned
- 2003-10-13 JP JP2004544592A patent/JP4672368B2/ja not_active Expired - Fee Related
- 2003-10-13 WO PCT/IB2003/004514 patent/WO2004035050A1/en not_active Ceased
- 2003-10-13 AT AT03748446T patent/ATE350034T1/de active
- 2003-10-13 DK DK03748446T patent/DK1553938T3/da active
- 2003-10-13 DE DE60310975T patent/DE60310975T2/de not_active Expired - Lifetime
-
2007
- 2007-03-15 CY CY20071100363T patent/CY1106385T1/el unknown
-
2011
- 2011-03-01 US US13/037,989 patent/US20110152329A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110152329A1 (en) | 2011-06-23 |
| DE60310975T2 (de) | 2007-07-12 |
| BR0315293A (pt) | 2005-08-30 |
| EP1553938A1 (en) | 2005-07-20 |
| DE60310975D1 (de) | 2007-02-15 |
| JP4672368B2 (ja) | 2011-04-20 |
| EP1553938B1 (en) | 2007-01-03 |
| AU2003267751A1 (en) | 2004-05-04 |
| WO2004035050A1 (en) | 2004-04-29 |
| CN1703217A (zh) | 2005-11-30 |
| DK1553938T3 (da) | 2007-03-26 |
| SI1553938T1 (sl) | 2007-06-30 |
| ES2279139T3 (es) | 2007-08-16 |
| CA2501717C (en) | 2012-09-18 |
| CN1297269C (zh) | 2007-01-31 |
| JP2006504751A (ja) | 2006-02-09 |
| ATE350034T1 (de) | 2007-01-15 |
| CA2501717A1 (en) | 2004-04-29 |
| US20060142354A1 (en) | 2006-06-29 |
| PT1553938E (pt) | 2007-03-30 |
| HK1080768A1 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
| CY1106283T1 (el) | Κινολινυλ-πυρρολοπυραζολες | |
| CY1113766T1 (el) | Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων | |
| CY1117584T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, cx3cr1 | |
| NO20052512L (no) | Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander | |
| BRPI0413152A (pt) | derivados de benzimidazol alquilado por n3 como inibidores de mek | |
| EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
| ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| CY1105603T1 (el) | Συνεργιστικοι συνδυασμοι που περιλαμβανουν εναν αναστολεα της ρενινης, για καρδιαγγειακες νοσους | |
| CY1112232T1 (el) | Κινολινικα παραγωγα ως αναστολεις φωσφοδιεστερασης | |
| CY1110019T1 (el) | Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες | |
| CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| ATE384058T1 (de) | Thiazolderivate | |
| CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
| CY1117504T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, και cx3cr1 | |
| CY1109013T1 (el) | Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν | |
| NO20043115L (no) | Substituerte diketopiperaziner som oksytocin antagonister | |
| CY1106026T1 (el) | Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας | |
| CY1112173T1 (el) | Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας | |
| EA200601249A1 (ru) | Пиперазины, пригодные для лечения боли | |
| CY1106385T1 (el) | Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου | |
| CY1105591T1 (el) | Αναστολεις για συνθαση του 20-ηετε | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты |